Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women (NCT06441474)

🧪 Interventions in This Study

• Presentation of personal breast cancer risk estimate (BEHAVIORAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• University of Colorado Denver — Aurora, Colorado
• Washington University in St. Louis — St Louis, Missouri

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Breast Cancer Female

• Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer — Tampa, Florida
• Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial — Phoenix, Arizona
• Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer — Charlottesville, Virginia
• Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes — Detroit, Michigan
• Robotic vs. Open NSM for Early Stage Breast Cancer — Irvine, California

Explore by condition: All Breast Cancer Female clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.